seekingalpha.com · Nov 12, 2025
Clearwater Analytics: Q3 Figures Show Enfusion Acquisition Brings Meaningful Growth
Clearwater Analytics is rated a Strong Buy, trading at a discount despite robust SaaS-driven growth and successful Enfusion integration. The Enfusion acquisition doubled CWAN's total addressable market, enhanced platform capabilities, and improved revenue visibility with a 98% retention rate. CWAN's scalable SaaS model, strong EBITDA, and aggressive debt paydown strategy mitigate concerns over its $800 million debt load.

